Tralokinumab improves clinical scores in adolescents with severe atopic dermatitis: A real-life multicentric observational study

J Eur Acad Dermatol Venereol. 2024 Mar;38(3):e288-e290. doi: 10.1111/jdv.19605. Epub 2023 Nov 10.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Observational Study

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal / therapeutic use
  • Dermatitis, Atopic* / drug therapy
  • Double-Blind Method
  • Humans
  • Injections, Subcutaneous
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • tralokinumab